Skip to main content
Erschienen in: International Ophthalmology 5/2016

14.01.2016 | Original Paper

Outcomes of different concentrations of human amniotic fluid in a keratoconjunctivitis sicca-induced mouse model

verfasst von: Guilherme G. Quinto, Juan Castro-Combs, Li Li, Navin Gupta, Mauro Campos, Ashley Behrens

Erschienen in: International Ophthalmology | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Abstract

To compare the effects of different concentrations of topical human amniotic fluid (HAF) in a mouse model of dry eye, forty C57BL/6 mice were divided into 4 treatment groups: 20 % HAF, 50 % HAF, 100 % HAF, and isotonic salt solution (control). Dry eye was induced by an injection of botulinum toxin B into the lacrimal gland. Tear production, ocular surface fluorescein staining, and blink rate were evaluated in each mouse at 5 time points during a 4-week period. Goblet cell density was assessed in stained histological sections. Regarding tear production, 20, 50, and 100 % HAF groups were all different from the control group (P < 0.001) at week 1. However, there were no statistically significant differences between the 20, 50, and 100 % HAF groups. At week 2, 20, 50, and 100 % HAF groups had significant improvement in staining score and were significantly different from the control group (P = 0.047, P = 0.005, and P = 0.001, respectively). No difference in spontaneous blink rate was observed between groups, at any time point. Goblet cell density was significantly decreased in the control group compared to the HAF treatment groups. All tested concentrations of topical HAF were effective and superior than the control in this keratoconjunctivitis sicca-induced mouse model. Further studies are needed to evaluate the effects of HAF on the human ocular surface.
Literatur
1.
Zurück zum Zitat Lemp MA (1995) Report of the National Eye Institute/Industry workshop on clinical trials in dry eye. CLAO J 21:221–232PubMed Lemp MA (1995) Report of the National Eye Institute/Industry workshop on clinical trials in dry eye. CLAO J 21:221–232PubMed
2.
Zurück zum Zitat Behrens A, Doyle JJ, Stern L et al (2006) Dysfunctional tear syndrome: a Delphi approach to treatment recommendations. Cornea 25:900–907CrossRefPubMed Behrens A, Doyle JJ, Stern L et al (2006) Dysfunctional tear syndrome: a Delphi approach to treatment recommendations. Cornea 25:900–907CrossRefPubMed
3.
Zurück zum Zitat Lemp MA, Foulks GN (2007) The definition and classification of dry eye disease. Report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop. Ocul Surf, 5:75–92 Lemp MA, Foulks GN (2007) The definition and classification of dry eye disease. Report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop. Ocul Surf, 5:75–92
7.
Zurück zum Zitat Stern ME, Beuerman RW, Fox RI et al (1998) The pathology of dry eye: the interaction between the ocular surface and lacrimal glands. Cornea 17:584–589CrossRefPubMed Stern ME, Beuerman RW, Fox RI et al (1998) The pathology of dry eye: the interaction between the ocular surface and lacrimal glands. Cornea 17:584–589CrossRefPubMed
8.
Zurück zum Zitat Liu L, Hartwig D, Harloff S et al (2005) An optimized protocol for the production of autologous serum eyedrops. Graefe’s Arch Clin Exp Ophthalmol 243:706–714CrossRef Liu L, Hartwig D, Harloff S et al (2005) An optimized protocol for the production of autologous serum eyedrops. Graefe’s Arch Clin Exp Ophthalmol 243:706–714CrossRef
9.
Zurück zum Zitat Foulks GN (2007) The correlation between the tear film lipid layer and dry eye disease. Surv Ophthalmol 52:369–374CrossRefPubMed Foulks GN (2007) The correlation between the tear film lipid layer and dry eye disease. Surv Ophthalmol 52:369–374CrossRefPubMed
11.
Zurück zum Zitat Fox RI, Chan R, Michelson JB et al (1984) Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca. Arthritis Rheum 27:459–461CrossRefPubMed Fox RI, Chan R, Michelson JB et al (1984) Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca. Arthritis Rheum 27:459–461CrossRefPubMed
12.
Zurück zum Zitat Noble BA, Loh RS, MacLennan S et al (2004) Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease. Br J Ophthalmol 88:647–652CrossRefPubMedPubMedCentral Noble BA, Loh RS, MacLennan S et al (2004) Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease. Br J Ophthalmol 88:647–652CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Kojima T, Ishida R, Dogru M et al (2005) The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study. Am J Ophthalmol 139:242–246CrossRefPubMed Kojima T, Ishida R, Dogru M et al (2005) The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study. Am J Ophthalmol 139:242–246CrossRefPubMed
14.
Zurück zum Zitat Noda-Tsuruya T, Asano-Kato N, Toda I et al (2006) Autologous serum eye drops for dry eye after LASIK. J Refract Surg 22:61–66PubMed Noda-Tsuruya T, Asano-Kato N, Toda I et al (2006) Autologous serum eye drops for dry eye after LASIK. J Refract Surg 22:61–66PubMed
15.
Zurück zum Zitat Tsubota K, Goto E, Fujita H et al (1999) Treatment of dry eye by autologous serum application in Sjögren’s syndrome. Br J Ophthalmol 83:390–395CrossRefPubMedPubMedCentral Tsubota K, Goto E, Fujita H et al (1999) Treatment of dry eye by autologous serum application in Sjögren’s syndrome. Br J Ophthalmol 83:390–395CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Longaker MT, Adzick NS, Hall JL et al (1990) Studies in fetal wound healing, VII. Fetal wound healing may be modulated by hyaluronic acid stimulating activity in amniotic fluid. J Pediatr Surg 25:430–433CrossRefPubMed Longaker MT, Adzick NS, Hall JL et al (1990) Studies in fetal wound healing, VII. Fetal wound healing may be modulated by hyaluronic acid stimulating activity in amniotic fluid. J Pediatr Surg 25:430–433CrossRefPubMed
18.
Zurück zum Zitat Longaker MT, Chiu ES, Adzick NS et al (1991) Studies in fetal wound healing V. A prolonged presence of hyaluronic acid characterizes fetal wound fluid. Ann Surg 213:292–296CrossRefPubMedPubMedCentral Longaker MT, Chiu ES, Adzick NS et al (1991) Studies in fetal wound healing V. A prolonged presence of hyaluronic acid characterizes fetal wound fluid. Ann Surg 213:292–296CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Lee HS, Kim JC (1996) Effect of amniotic fluid in corneal sensitivity and nerve regeneration after excimer laser ablation. Cornea 15:517–524PubMed Lee HS, Kim JC (1996) Effect of amniotic fluid in corneal sensitivity and nerve regeneration after excimer laser ablation. Cornea 15:517–524PubMed
20.
Zurück zum Zitat Herretes S, Suwan-Apichon O, Pirouzmanesh A et al (2006) Use of topical human amniotic fluid in the treatment of acute ocular alkali injuries in mice. Am J Ophthalmol 142:271–278CrossRefPubMed Herretes S, Suwan-Apichon O, Pirouzmanesh A et al (2006) Use of topical human amniotic fluid in the treatment of acute ocular alkali injuries in mice. Am J Ophthalmol 142:271–278CrossRefPubMed
21.
Zurück zum Zitat Ozgenel GY, Filiz G (2003) Effects of human amniotic fluid on peripheral nerve scarring and regeneration in rats. J Neurosurg 98:371–377CrossRefPubMed Ozgenel GY, Filiz G (2003) Effects of human amniotic fluid on peripheral nerve scarring and regeneration in rats. J Neurosurg 98:371–377CrossRefPubMed
22.
Zurück zum Zitat al-Qattan MM, Posnick JC, Lin KY (1995) The in vivo response of fetal tendons to sutures. J Hand Surg (British European Volume) 20:314–318CrossRef al-Qattan MM, Posnick JC, Lin KY (1995) The in vivo response of fetal tendons to sutures. J Hand Surg (British European Volume) 20:314–318CrossRef
23.
Zurück zum Zitat Quinto GG, Camacho W, Castro-Combs J et al (2012) Effects of topical human amniotic fluid and human serum in a mouse model of keratoconjunctivitis sicca. Cornea 31:424–430CrossRefPubMed Quinto GG, Camacho W, Castro-Combs J et al (2012) Effects of topical human amniotic fluid and human serum in a mouse model of keratoconjunctivitis sicca. Cornea 31:424–430CrossRefPubMed
24.
Zurück zum Zitat Suwan-Apichon O, Rizen M, Rangsin R et al (2006) Botulinum toxin B-induced mouse model of keratoconjunctivitis sicca. Invest Ophthalmol Vis Sci 47:133–139CrossRefPubMed Suwan-Apichon O, Rizen M, Rangsin R et al (2006) Botulinum toxin B-induced mouse model of keratoconjunctivitis sicca. Invest Ophthalmol Vis Sci 47:133–139CrossRefPubMed
25.
Zurück zum Zitat Nakamura S, Shibuya M, Nakashima H et al (2005) d-Beta-hydroxybutyrate protects against corneal epithelial disorders in a rat dry eye model with jogging board. Invest Ophthalmol Vis Sci 46:2379–2387CrossRefPubMed Nakamura S, Shibuya M, Nakashima H et al (2005) d-Beta-hydroxybutyrate protects against corneal epithelial disorders in a rat dry eye model with jogging board. Invest Ophthalmol Vis Sci 46:2379–2387CrossRefPubMed
26.
Zurück zum Zitat Cho CK, Shan SJ, Winsor EJ et al (2007) Proteomics analysis of human amniotic fluid. Mol Cell Proteomics 6:1406–1415CrossRefPubMed Cho CK, Shan SJ, Winsor EJ et al (2007) Proteomics analysis of human amniotic fluid. Mol Cell Proteomics 6:1406–1415CrossRefPubMed
27.
Zurück zum Zitat Lekhanont K, Leyngold IM, Suwan-Apichon O et al (2007) Comparison of topical dry eye medications for the treatment of keratoconjunctivitis sicca in a botulinum toxin B-induced mouse model. Cornea 26:84–89CrossRefPubMed Lekhanont K, Leyngold IM, Suwan-Apichon O et al (2007) Comparison of topical dry eye medications for the treatment of keratoconjunctivitis sicca in a botulinum toxin B-induced mouse model. Cornea 26:84–89CrossRefPubMed
28.
Zurück zum Zitat Barabino S, Shen L, Chen L et al (2005) The controlled-environment chamber: a new mouse model of dry eye. Invest Ophthalmol Vis Sci 46:2766–2771CrossRefPubMed Barabino S, Shen L, Chen L et al (2005) The controlled-environment chamber: a new mouse model of dry eye. Invest Ophthalmol Vis Sci 46:2766–2771CrossRefPubMed
30.
Zurück zum Zitat Pflugfelder SC, Tseng SC, Yoshino K et al (1997) Correlation of goblet cell density and mucosal epithelial membrane mucin expression with rose bengal staining in patients with ocular irritation. Ophthalmology 104:223–235CrossRefPubMed Pflugfelder SC, Tseng SC, Yoshino K et al (1997) Correlation of goblet cell density and mucosal epithelial membrane mucin expression with rose bengal staining in patients with ocular irritation. Ophthalmology 104:223–235CrossRefPubMed
Metadaten
Titel
Outcomes of different concentrations of human amniotic fluid in a keratoconjunctivitis sicca-induced mouse model
verfasst von
Guilherme G. Quinto
Juan Castro-Combs
Li Li
Navin Gupta
Mauro Campos
Ashley Behrens
Publikationsdatum
14.01.2016
Verlag
Springer Netherlands
Erschienen in
International Ophthalmology / Ausgabe 5/2016
Print ISSN: 0165-5701
Elektronische ISSN: 1573-2630
DOI
https://doi.org/10.1007/s10792-016-0180-0

Weitere Artikel der Ausgabe 5/2016

International Ophthalmology 5/2016 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.